Senior insider sale
CHIEF ACCOUNTING OFFICER at DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$2.05M
20K shares
What this filing means
CARR EDWARD plans to sell 20K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $2.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/17/2026ACC: 0001950047-26-009619
Officer· CHIEF ACCOUNTING OFFICER
Since Mar 2026
20K
Shares to sell
$2.05M
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/17/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/17/2026 | Exercise of Stock Options Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20K
Market value
$2.05M
9/17/2026
Total
Units
20K
Value
$2.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/17/2026 | 20K | $2.05M | NASDAQ | Planned |
| Total | 20K | $2.05M | ||